Pharmaceuticals/Biotech
Roche Closing California Lab
September 5, 2008 5:22 am | News | CommentsSwiss drug maker is planning to shutter its 1,000-worker Palo Alto research lab as it pursues its takeover bid for Genentech Inc.
Alpharma Plans To Head Off King Takeover
September 2, 2008 11:40 am | News | CommentsAfter rejecting a $1.4 billion offer from King in August, on Tuesday Alpharma's board adopted a shareholders rights plan to head off a hostile takeover bid.
U.S. Regulators Okay Fresenius Takeover Of APP
September 2, 2008 11:20 am | News | CommentsAPP Pharmaceuticals said Tuesday it expects the deal to close by mid-September, now that the Federal Trade Commission has completed its review of the $3.7 billion deal.
Shionogi To Buy Sciele Pharma For $1.4 Billion
September 2, 2008 6:30 am | News | CommentsJapanese drug maker said it would buy U.S. pharmaceutical company in a bid to expand its business operations in the American market.
Life Sciences Companies Expanding In Massachusetts
September 2, 2008 5:40 am | News | CommentsSiemens Healthcare Diagnostics, Advance Medical Inc., and Covidien are all planning to expand operations in Massachusetts.
Drugmaker UCB Cutting 2,000 Jobs
August 28, 2008 5:48 am | by Aoife White, AP Business Writer | News | CommentsBelgian pharmaceutical company to shed nearly a fifth of its work force as revenues are expected to fall because of the expiration of exclusive patents for older medicines.
Otsuka Pharmaceutical Purchases Czech Firm
August 26, 2008 5:25 am | News | CommentsJapanese company said Tuesday it has acquired an entire stake in Interpharma Praha, a.s., a Czech drug maker strong in pharmaceutical ingredients and nutrition products.
King Pharmaceuticals Offers Alpharma $1.4 Billion
August 22, 2008 6:20 am | News | CommentsDrugmaker said its unsolicited buyout bid for Alpharma is part of a move to create a large diverse specialty pharmaceutical company and expand its pain therapy products.
Genentech To Pay $371 Million For Retention Plan
August 22, 2008 5:36 am | News | CommentsEmployee retention plan announced along with Genentech's rejection of Roche's buyout offer will cost the biotechnology giant about $371 million.
Monsanto Sells Cow Hormones To Eli Lilly For $300M
August 20, 2008 6:20 am | News | CommentsAgricultural chemical company agreed to sell its Posilac brand of cow hormones to drug maker Eli Lilly & Co.'s Elanco animal health unit.
Jobs Slip In N.J. Pharmaceuticals
August 18, 2008 11:07 am | News | CommentsLayoffs and restructurings are taking a toll on drug and medical technology companies in New Jersey, one of the state's most important industries.
Flu Vaccine Makers Begin Shipping Doses Early
August 14, 2008 11:25 am | by Linda A. Johnson, AP Business Writer | News | CommentsAll but one of the five manufacturers expected to supply a record 143 million doses to the U.S. began shipping the vaccine in the past two weeks, several weeks earlier than usual.
Genentech Turns Down Roche's $43.7B Bid
August 13, 2008 6:20 am | News | CommentsBiotechnology giant rejects a buyout offer from its majority owner Roche, saying the $43.7 billion takeover bid undervalues the company.
Enzon Considers Selling Specialty Pharma Unit
August 11, 2008 6:55 am | News | CommentsCompany could possibly sell its specialty pharmaceuticals unit as it moves forward with a spinoff of its biotechnology division.
ImClone Says Bristol-Myers’ Offer Is Low
August 4, 2008 11:07 am | by Damian J. Troise, AP Business Writer | News | CommentsDespite calling the $4.5 billion buyout offer too low, ImClone said its board formed a committee to weigh the offer from cancer drug partner Bristol-Myers Squibb.
Bristol-Myers Offers $4.5B For ImClone
July 31, 2008 5:10 am | News | CommentsDrug developer offered $4.5 billion in cash for its cancer drug partner Thursday, though the biotechnology company's board has yet to comment on the proposal.
FDA Seizes $24 Million In Unapproved Drugs
July 30, 2008 12:35 pm | News | CommentsGovernment agencies have seized more than $24 million worth of unapproved new drugs from St. Louis-based KV Pharmaceutical Co.
Oregon Bioscience Industry Struggles To Grow
July 28, 2008 6:25 am | by Bennett Hall, AP Writer | News | CommentsShortage of qualified workers, limited access to capital and lack of space hinder the state’s bioscience industry, but organizing efforts are helping address the challenges holding it back.
Sanofi To Buy Vaccine Maker Acambis
July 28, 2008 5:35 am | News | CommentsDeal would add Acambis' key smallpox vaccine ACAM2000 to the existing portfolio of Sanofi Pasteur, the vaccines business of Sanofi-Aventis.
Genentech Committee To Study Roche Bid
July 25, 2008 5:22 am | News | CommentsCompany has officially formed a special committee consisting of its three independent board members to consider Roche Holding's takeover bid.
Roche Sued Over Genentech Bid
July 24, 2008 6:10 am | News | CommentsLawsuit claims the Swiss pharmaceutical company is offering too little in its takeover bid for Genentech Inc.
Roche Buys Arius In Biotech Spending Spree
July 23, 2008 5:18 am | News | CommentsPharmaceutical giant plans to buy Arius Research Inc. for $190.4 million as the latest in a series of purchases of North American biotechnology companies.
Teva Finalizes Bentley Pharmaceuticals Acquisition
July 23, 2008 5:10 am | News | CommentsIsraeli generic drug maker completed a $360 million acquisition of Bentley Pharmaceuticals, which will expand its operations in Spain.
Roche Buying Mirus Bio
July 22, 2008 5:22 am | News | CommentsPharmaceutical company Roche Holding will buy U.S. gene therapy company Mirus Bio Corp. for $125 million.
Analysts: Roche Bid For Genentech Too Low
July 21, 2008 6:39 am | News | CommentsRoche's $43.7 billion bid to takeover Genentech may be too low, several analysts said, and investors seemed to agree, driving shares well above the value of the buyout offer.
